|"The Restless Legs Syndrome Foundation is dedicated to improving the lives of the men, women, and children who live with this often devastating disease. The organization's goals are to increase awareness of restless legs syndrome (RLS), to improve treatments, and through research, to find a cure." (http://www.rls.org/NetCommunity/Page.aspx?&pid=329&srcid=178; accessed 11/3/06) |
Corporate Sponsors Include:
$10,000+ (http://www.rls.org/NetCommunity/Document.Doc?&id=23; accessed 11/3/06)
- Boehringer Ingelheim Pharmaceuticals, Inc.
- XenoPort, Inc.
The Restless Legs Syndrome Foundation was cited in an article in the New Scientist as having received 44 percent of its total funding of $1,430,765 from donations from pharmaceutical/ device companies. (Marshall, Jessica and Aldous, Peter. "Patient groups special: Swallowing the best advice?" New Scientist, 10/27/06, p.1)
RLS Foundation "gets about $450,000 in funding from GlaxoSmithKline." (Stein, Rob. "Marketing the Illness and the Cure?" the Washington Post, 5/30/06, p.A03)